Discontinued — last reported Q3 '25
This is a positive signal — lower values indicate better performance for this metric.
Higher costs indicate significant strategic shifts or business unit rationalization, whereas lower costs suggest operational continuity.
Captures expenses associated with exiting specific business activities, facilities, or product lines within the Prescrip...
Comparable to 'exit costs' or 'discontinued operations expenses' found in the segment reporting of large healthcare service providers.
mck_segment_prescription_technology_solutions_exit_and_other_related_costs| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $0.00 | $0.00 | $2.00M | $1.00M | $1.00M | $1.00M | $2.00M | $3.00M | $1.00M | $8.00M | $3.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +0.0% | -100.0% | — | — | -50.0% | +0.0% | +0.0% | +100.0% | +50.0% | -66.7% | +700.0% | -62.5% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | +100.0% | +0.0% | — | — | +0.0% | +200.0% | +0.0% | +700.0% | +50.0% | -100.0% | -100.0% | -100.0% | — |